PAROXETINE, A POTENT SELECTIVE LONG-ACTING INHIBITOR OF SYNAPTOSOMAL 5-HT UPTAKE IN MICE

被引：41

作者：

MAGNUSSEN, I ^{[1
]}

TONDER, K ^{[1
]}

ENGBAEK, F ^{[1
]}

机构：

[1] AARHUS UNIV HOSP,DEPT CLIN CHEM,METAB DISORDERS RES LAB,DK-8000 AARHUS C,DENMARK

来源：

JOURNAL OF NEURAL TRANSMISSION | 1982年 / 55卷 / 03期

关键词：

D O I：

10.1007/BF01276577

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

引用

页码：217 / 226

页数：10

共 14 条

[1] POTENT AND LONG-LASTING POTENTIATION OF 2 5-HYDROXYTRYPTOPHAN-INDUCED EFFECTS IN MICE BY 3 SELECTIVE 5-HT UPTAKE INHIBITORS [J].

BUUSLASSEN, J .

EUROPEAN JOURNAL OF PHARMACOLOGY, 1978, 47 (03) :351-358

[2] CENTRAL AND PERIPHERAL 5-HT UPTAKE IN RATS TREATED CHRONICALLY WITH FEMOXETINE, PAROXETINE, AND CHLORIMIPRAMINE [J].

BUUSLASSEN, J ;

LUND, J ;

SONDERGAARD, I .

PSYCHOPHARMACOLOGY, 1980, 68 (03) :229-233

[3] CLINICAL, BIOCHEMICAL, AND PHYSIOLOGICAL FEATURES DISTINGUISHING MYOCLONUS RESPONSIVE TO 5-HYDROXYTRYPTOPHAN, TRYPTOPHAN WITH A MONOAMINE-OXIDASE INHIBITOR, AND CLONAZEPAM [J].

CHADWICK, D ;

HALLETT, M ;

HARRIS, R ;

JENNER, P ;

REYNOLDS, EH ;

MARSDEN, CD .

BRAIN, 1977, 100 (SEP) :455-487

[4]

DELEAN J, 1976, NEUROLOGY, V26, P863

[5]

ENGBAEK F, 1982, CLIN CHEM, V28, P624

[6]

KUHAR MJ, 1972, J PHARMACOL-PARIS, V181, P36

[7]

LOUS P, 1956, NORD MED, V55, P693

[8]

LUND J, 1979, ACTA PHARMACOL TOX, V44, P289

[9] TREATMENT OF MYOCLONIC SYNDROMES WITH PAROXETINE ALONE OR COMBINED WITH 5-HTP [J].

MAGNUSSEN, I ;

MONDRUP, K ;

ENGBAEK, F ;

LADEMANN, A ;

OLIVARIUS, BD .

ACTA NEUROLOGICA SCANDINAVICA, 1982, 66 (02) :276-282

[10] EFFECT OF IPRONIAZID AND IMIPRAMINE ON THE BLOOD PLATELET 5-HYDROXYTRYPTAMINE LEVEL IN MAN [J].

MARSHALL, EF ;

STIRLING, GS ;

TAIT, AC ;

TODRICK, A .

BRITISH JOURNAL OF PHARMACOLOGY AND CHEMOTHERAPY, 1960, 15 (01) :35-41

← 1 2 →